Albany Molecular Research Inc
AMRI
AMRI was delisted on the 31st of August, 2017.
118 hedge funds and large institutions have $264M invested in Albany Molecular Research Inc in 2013 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 28 reducing their positions, and 9 closing their positions.
167% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 9
82% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 28
15% more funds holding
Funds holding: 103 → 118 (+15)
13% more call options, than puts
Call options by funds: $1.43M | Put options by funds: $1.26M
2% less capital invested
Capital invested by funds: $269M → $264M (-$4.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$28.4M |
| 2 |
VAM
Visium Asset Management
New York
|
+$13.5M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$6.67M |
| 4 |
RA
Royce & Associates
New York
|
+$5.05M |
| 5 |
JP Morgan Chase
New York
|
+$3.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$4.57M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$3.62M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$3.6M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$2.48M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.84M |
AMRI Hedge Fund Activity: Q4 2013 in Review
118 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q4 2013, worth a combined $264M — down 1.6% from $269M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new AMRI positions and 9 closed out — a net gain of 15 holders — while 51 added to existing stakes and 28 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $28.4M. The largest seller was Fuller & Thaler Asset Management, exiting entirely with an estimated $4.57M sold.
- 118 institutional investors held Albany Molecular Research Inc (AMRI) as of Q4 2013, up from 103 in Q3 2013.
- Funds reported $264M of Albany Molecular Research Inc stock for Q4 2013, down 1.6% quarter-over-quarter.
- 24 funds opened new Albany Molecular Research Inc positions in Q4 2013 and 9 closed out, a net change of +15 holders.
- The largest Albany Molecular Research Inc buyer in Q4 2013 was Wellington Management Group, an estimated $28.4M added.
- The largest Albany Molecular Research Inc seller in Q4 2013 was Fuller & Thaler Asset Management, an estimated $4.57M sold.
Based on aggregated 13F filings for Q4 2013.